Ropivacaine 0.75% (Naropin®) compared with mepivacaine 2% (Scandicain®)
and bupivacaine 0.5%(Carbostesin®) as local anesthetics for the retrobulbar
catheter technique
1Jäger M., 2Hemmerling T., 1Jonas J. B.
1Augenklinik, Fakultät für klinische Medizin Mannheim, Ruprecht-Karls-Universität
Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, 2Department of Anesthesiology,
Department of Anesthesiology, Centre Hospitalier de l'Université
de Montréal (CHUM), University of Montréal, Canada
Purpose: The prospective randomised double masked study compared
three local anesthetics of different onset and duration of action to determine
the best anesthetic for pain control during and after intraocular surgery
with an indwelling retrobulbar catheter.
Methods: Since December 2000, 54 patients undergoing ocular surgery
such as pars plana vitrecomy (n=34), scleral buckling procedures (n=11)
or kryocoagulation (n=9) have been randomised to receive either 8ml bupivacaine
0.5%, ropivacaine 0.75% or mepivacaine 2% (each n= 18) through an retrobulbar
needle (diameter 0.8mm, lenghth 38mm) before surgery. Additionally, an
indwelling catheter was introduced through the same needle into the retrobulbar
space. When the patients started to feel pain intra- or postoperatively
2ml of the same anesthetic were injected through the inserted retrobulbar
catheter.
Results: The mean duration of surgery was 67.78±45.56 minutes.
The mean amount of re-injected anesthetic (9.11±1.77ml) and the
frequency of re-injections (1,56±0,86) during surgery was lowest
in the ropivacaine group without being statistically significant between
the three groups. The mean time of the first reinjection was significantly
shorter after mepivacaine injection (28,33±17,14 minutes) than
bupivacaine or ropivacaine. Additional subconjuntival injections were
performed in one patient of the ropivacaine group, and in 6 patients of
the bupivacaine-group. Six patients of the bupivacaine-group received
systemic analgetics and 3 patients of the mepivacaine group. Intraoperatively,
the ropivacaine group had the lowest pain score. Postoperatively, the
patients of the bupivacaine-group showed a reduced need for reinjections
(0.56±0.92) and anesthetic volume (1.11±1.84ml), they demanded
re-injections later (270±162.56 minutes) than the patients of the
two other study groups. The patients of the bupivacaine group had the
lowest pain score after surgery: Five patients with bupivacaine needed
additional systemic analgesics compared to 15 patients with mepivacaine.
The bupivacaine anesthesia provided a longer ocular akinesia.
Conclusion: Combination of a short-acting local anesthetics such
as mepivacain during surgery with a long-acting local anesthetics for
postoperative re-injections may be useful for anethesia using an indwelling
retrobulbar catheter in intraocular surgery.
|